ES537330A0 - Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada - Google Patents

Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada

Info

Publication number
ES537330A0
ES537330A0 ES537330A ES537330A ES537330A0 ES 537330 A0 ES537330 A0 ES 537330A0 ES 537330 A ES537330 A ES 537330A ES 537330 A ES537330 A ES 537330A ES 537330 A0 ES537330 A0 ES 537330A0
Authority
ES
Spain
Prior art keywords
peptide
exo
procedure
producing
desired protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537330A
Other languages
English (en)
Other versions
ES8600403A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of ES8600403A1 publication Critical patent/ES8600403A1/es
Publication of ES537330A0 publication Critical patent/ES537330A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/30Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ES537330A 1983-03-09 1984-11-02 Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada Granted ES537330A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/473,820 US4711844A (en) 1983-03-09 1983-03-09 Modified signal peptides

Publications (2)

Publication Number Publication Date
ES8600403A1 ES8600403A1 (es) 1985-09-16
ES537330A0 true ES537330A0 (es) 1985-09-16

Family

ID=23881126

Family Applications (2)

Application Number Title Priority Date Filing Date
ES537329A Expired ES8507613A1 (es) 1983-03-09 1984-11-02 Un procedimiento para producir una secuencia de adn que codifica un peptido de exo-senal
ES537330A Granted ES537330A0 (es) 1983-03-09 1984-11-02 Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES537329A Expired ES8507613A1 (es) 1983-03-09 1984-11-02 Un procedimiento para producir una secuencia de adn que codifica un peptido de exo-senal

Country Status (9)

Country Link
US (1) US4711844A (es)
EP (1) EP0138948B1 (es)
JP (1) JPS60500701A (es)
DE (1) DE3476557D1 (es)
DK (1) DK534584A (es)
ES (2) ES8507613A1 (es)
FI (1) FI844375A0 (es)
IT (1) IT1199087B (es)
WO (1) WO1984003519A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411873A (en) * 1984-05-29 1995-05-02 Genencor, Inc. Process for producing heterologous polypeptides
US5840522A (en) * 1984-09-20 1998-11-24 Chiron Corporation Recombinant lectins
EP0177343B1 (en) * 1984-10-05 1992-07-22 Genentech, Inc. Dna, cell cultures and methods for the secretion of heterologous proteins and periplasmic protein recovery
US4963495A (en) * 1984-10-05 1990-10-16 Genentech, Inc. Secretion of heterologous proteins
DE3436818A1 (de) * 1984-10-06 1986-04-10 Hoechst Ag, 6230 Frankfurt Synthetische signalsequenz zum transport von proteinen in expressionssystemen
IT1177378B (it) * 1984-12-11 1987-08-26 Anic Spa Vettore plasmidico psm112 ad espressione in bacillus subtilis
US6084073A (en) * 1985-03-25 2000-07-04 Chiron Corporation Recombinant ricin toxin
JPH0669377B2 (ja) * 1985-11-25 1994-09-07 工業技術院長 Dna塩基配列およびベクタ−
DE3650692T2 (de) * 1986-03-07 1999-04-22 Chiron Corp Rekombinantes Ricin-Toxin
US4987070A (en) * 1987-03-04 1991-01-22 Suntory Limited Use of a 97 amino acid leader sequence from the E. coli B-galactosidase gene for the production of hanp and hptc as fusion proteins
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
WO1988009821A1 (en) * 1987-06-12 1988-12-15 Massachusetts Institute Of Technology Coryneform expression and secretion system
US5171673A (en) * 1988-07-18 1992-12-15 Biotechnica International, Inc. Expression of heterologous dna using the bacillus coagulans amylase gene
US5037743A (en) * 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5284768A (en) * 1988-08-24 1994-02-08 Sanofi Signal peptide, DNA sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide
US5028593A (en) * 1989-08-15 1991-07-02 Board Of Regents, The University Of Texas System Tuftsin analogs
EP0625052A4 (en) * 1991-10-21 1995-07-19 Medimmune Inc SECRETION SIGNAL OF LIPOPROTEIN-ENCODING DNA CONTAINING BACTERIAL EXPRESSION VECTOR.
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences
FR2708622B1 (fr) * 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
EP0984065A4 (en) * 1997-02-14 2002-07-24 Higeta Shoyu Kk MODIFIED PROTEINANTIGENT FROM TREPONEMA PALLADIUM.
US6017694A (en) * 1997-12-19 2000-01-25 American Cyanamid Company Methods of screening for modulators of respiratory syncytial virus matrix protein interaction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
US4351901A (en) * 1980-03-24 1982-09-28 Cetus Corporation Method for single nucleotide alteration
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
GB8308483D0 (en) * 1983-03-28 1983-05-05 Health Lab Service Board Secretion of gene products

Also Published As

Publication number Publication date
JPS60500701A (ja) 1985-05-16
EP0138948A1 (en) 1985-05-02
US4711844A (en) 1987-12-08
IT8447831A1 (it) 1985-09-09
ES537329A0 (es) 1985-09-01
DK534584D0 (da) 1984-11-09
FI844375L (fi) 1984-11-07
IT1199087B (it) 1988-12-30
EP0138948B1 (en) 1989-02-01
WO1984003519A1 (en) 1984-09-13
DK534584A (da) 1984-11-09
ES8600403A1 (es) 1985-09-16
IT8447831A0 (it) 1984-03-09
DE3476557D1 (en) 1989-03-09
FI844375A0 (fi) 1984-11-07
ES8507613A1 (es) 1985-09-01

Similar Documents

Publication Publication Date Title
ES537330A0 (es) Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada
ES535511A0 (es) Un metodo para producir una proteina heterologa madura.
ES531898A0 (es) Procedimiento para obtener una proteina heterologa para levadura
ES526849A0 (es) Un procedimiento para producir un aglutinante adhesivo proteinico modificado
ES535125A0 (es) Un procedimiento para la preparacion de un peptido en forma sustancialmente pura.
ES537994A0 (es) Un metodo de producir una proteina de interleuquina-2-humana no glicosilada sustancialmente pura
ES551483A0 (es) Procedimiento para la purificacion de una proteina
ES537440A0 (es) Un procedimiento para preparar 1-amino-4-nitro-acridinonas sustituidas
ES520997A0 (es) Un metodo para producir un peptido.
MX165063B (es) Procedimiento para hacer acidos alcansulfonicos anhidros
ES529232A0 (es) Un metodo de producir un peptido o polipeptido sintetico.
ES557321A0 (es) Procedimiento para producir un material fotomodulador
MX161186A (es) Procedimiento para preparar peptidos
ES532859A0 (es) Un procedimiento para producir fenilalanina
ES536152A0 (es) Un procedimiento para producir l-arginina
ES531897A0 (es) Procedimiento para obtener una proteina heterologa para levaduras
MX7572E (es) Procedimiento para preparar proteina unicelular
ES555649A0 (es) Un metodo para eliminar la metionina n-terminal de una metionil-proteina
ES485269A0 (es) Un procedimiento para la preparacion de un peptido
ES544316A0 (es) Un metodo para preparar un peptido
FR2549070B1 (fr) Nouveau peptide
ES542019A0 (es) Procedimiento para producir una n-acilfenilalanina
MX156049A (es) Un procedimiento para la preparacion de una n - piperazinilalcanolanilida
ES501878A0 (es) Un procedimiento para preparar un peptido
ES551704A0 (es) Un procedimiento para producir un anticuerpo monoclonal